Anne-Marie Zanzal, 60, and her wife Tonda McKay, 62, have also experienced the more positive changes that weight-loss drugs ...

It outperformed Orexigen's Mysimba/Contrave weight loss drug, where around a quarter of patients in a phase 3 trial achieved the target. Semaglutide came out top of the analysis, with 63% of ...

The rise of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss has encouraged many patients ... phentermine kept its place as the most dispensed drug for obesity, going from 648,000 ...

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

Obesity drug prescriptions rose from 760,000 in July ... and GLP-1-based drugs for diabetes management that also confer weight loss were obtained from the IQVIA National Prescription Audit.

To learn more about how Americans think about weight and weight loss, Hims & Hers conducted a ... birth control pills, and corticosteroids may cause weight fluctuations. Social and cultural ...

The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be fu ...

Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

Feb 20 (Reuters) - Eli Lilly (LLY.N), opens new tab is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by recording nearly $550 million ...